Shiley Samuel G, Hargunani Christopher A, Skoner Judith M, Holland John M, Wax Mark K
Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Otolaryngol Head Neck Surg. 2006 Mar;134(3):455-9. doi: 10.1016/j.otohns.2005.10.054.
Advanced-stage oropharyngeal cancer may be treated either surgically or nonsurgically. We reported previously functional outcomes after surgical resection with free-tissue transfer. In the present study, we evaluated swallowing function after combined chemoradiation for oropharyngeal cancer.
Retrospective review of 30 patients treated at a tertiary academic center for Stage III/IV oropharyngeal cancer with sequential or concurrent chemoradiation from 1994 to 2003.
Inclusion criteria were met by 27 of 30 (90%) patients. Most patients had base of tongue lesions (67%) and Stage IV disease (93%). Gastrostomy was carried out in 22 (82%) patients either before or during treatment. Three months after chemoradiation, 33% (9/27) were consuming all nutrition orally, 22% (6 of 27) were NPO, and 45% (12 of 27) had some oral intake but still required tube feeds. One year after treatment, 53% (10 of 19) had an exclusively oral diet whereas 47% still required tube feeds including 1 patient (5%) who was NPO. In patients without recurrence and follow-up length >1 year, 69% (9 of 13) were consuming all nutrition orally whereas 31% still required gastrostomy tube (G-tube) support. A higher rate of G-tube dependence was observed in patients treated for base of tongue lesions vs tonsil lesions (67% vs 25%, P = 0.049, chi(2) analysis).
At this institution, the short-term (3-4 months) rate of G-tube dependence was similar after surgical and non-surgical treatment of oropharyngeal cancer. One year after chemoradiation, 31% of patients without recurrence still required tube feeds.
These results suggest that organ-preservation protocols do not reduce the prevalence of chronic dysphagia and G-tube dependence after management of oropharyngeal cancer.
C-4.
晚期口咽癌可以采用手术或非手术治疗。我们之前报道了游离组织移植手术切除后的功能结果。在本研究中,我们评估了口咽癌同步放化疗后的吞咽功能。
回顾性分析1994年至2003年在一家三级学术中心接受序贯或同步放化疗的30例III/IV期口咽癌患者的资料。
30例患者中有27例(90%)符合纳入标准。大多数患者有舌根病变(67%)和IV期疾病(93%)。22例(82%)患者在治疗前或治疗期间进行了胃造口术。放化疗3个月后,33%(9/27)的患者完全经口摄取所有营养,22%(27例中的6例)禁食,45%(27例中的12例)有部分经口摄入但仍需要管饲。治疗1年后,53%(19例中的10例)完全经口饮食,而47%仍需要管饲,其中1例患者(5%)禁食。在无复发且随访时间>1年的患者中,69%(13例中的9例)完全经口摄取所有营养,而31%仍需要胃造口管(G管)支持。与扁桃体病变患者相比,舌根病变患者的G管依赖率更高(67%对25%,P = 0.049,卡方分析)。
在本机构,口咽癌手术和非手术治疗后短期(3 - 4个月)的G管依赖率相似。放化疗1年后,31%无复发的患者仍需要管饲。
这些结果表明,器官保留方案并不能降低口咽癌治疗后慢性吞咽困难和G管依赖的发生率。
C - 4